Hepatitis C treatment prescribing in Australia by provider, 2020-2022: the underestimated role of nurse practitioners
Intern Med J
.
2024 Apr;54(4):695-696.
doi: 10.1111/imj.16371.
Authors
Jennifer H MacLachlan
1
2
,
Mielle Abbott
1
2
,
Tracey Jones
3
,
Sinead Sheils
4
,
Jacqueline A Richmond
5
6
Affiliations
1
WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, Melbourne, Victoria, Australia.
2
Department of Infectious Diseases, University of Melbourne, Melbourne, Victoria, Australia.
3
Justice Health and Forensic Mental Health Network, Sydney, New South Wales, Australia.
4
Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, New South Wales, Australia.
5
Disease Elimination, Disease Elimination, Burnet Institute, Melbourne, Victoria, Australia.
6
Department of Nursing, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
PMID:
38637279
DOI:
10.1111/imj.16371
No abstract available
Publication types
Letter
MeSH terms
Australia / epidemiology
Drug Prescriptions
Hepatitis C* / drug therapy
Hepatitis C* / epidemiology
Humans
Nurse Practitioners*
Nurse's Role